2026 ECPR61 Inhaled Corticosteroid for Patients with Acute Asthma Exacerbation 

Measure Title: Inhaled Corticosteroid for Patients with Acute Asthma Exacerbation

Measure Description: Percentage of patients aged 6+ diagnosed with an acute asthma exacerbation and prescribed inhaled corticosteroid

Denominator: Any patient age 6 years or older evaluated by the Eligible Professional PLUS diagnosis of acute asthma PLUS disposition of discharged (admitted, transferred to another acute care facility (same or higher level of care), eloped, AMA, or expired patients are not included)

Numerator: Patients Who Did Have an Inhaled Corticosteroid Prescribed

Denominator Exclusions: None

Denominator Exceptions: Inhaled Corticosteroid not prescribed at discharge due to allergy, patient (or parent/guardian) refusal, active tuberculosis, untreated fungal or bacterial infections; or patient already prescribed inhaled corticosteroid.

High Priority Measure: No

Measure Type: Process

Includes Teleheatlh: Yes

Inverse Measure: No

Proportional Measure: Yes

Continuous Variable Measure: No

Ratio Measure: No

Number of performance rates to be calculated and submitted: 1

Risk-Adjusted Status: No

Care Setting: Emergency Department and Services; Ambulatory Care: Hospital; Ambulatory Care: Urgent Care; Hospital; Hospital Outpatient

Submission Pathway: Traditional MIPS


Tags

QCDR-EACCR-2026